Study on Mass Balance of [14C]HMPL-306（Isocitrate Dehydrogenase Inhibitor） in Healthy Chinese Adult Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

July 2, 2025

Conditions

Mass Balance Study

Interventions

DRUG

100 µCi [14C] HMPL-306

D1: 250 mg/100 µCi \[14C\] HMPL-306 Single dose

Trial Locations (1)

The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan